BIBP’s COVID-19 Vaccine Approved for Emergency Use in Sri Lanka
In the evening of March 19 local time, Channa Jayasumana, State Minister of Production, Supply and Regulation of Pharmaceuticals of Sri Lanka, announced that the National Medicines Regulatory Authority had granted emergency use approval to the Inactivated COVID-19 Vaccine (Vero Cell) developed by Beijing Institute of Biological Products Company Limited (CNBG), Si...
View More +
BIBP’s COVID-19 Vaccine Approved for Emergency Use in Lebanon
March 2 (www.haiwainet.cn)- On Monday (March 1) local time, a scientific committee set up by Hamad Hassan, Minister of Public Health of Lebanon Caretaker Cabinet, approved the Inactivated COVID-19 Vaccine (Vero Cell) developed by Beijing Institute of Biological Products Co., Ltd. (BIBP), China National Biotec GroupCompany Limited(CNBG), Sinopharm (BIBP’s COVID-19...
View More +
BIBP’s COVID-19 Vaccine Approved for Emergency Use in Nepal
On February 17 local time, the Department of Drug Administration of Nepal issued a notice to approve the Inactivated COVID-19 Vaccine (Vero Cell) developed by Beijing Institute of Biological Products Co., Ltd.(BIBP), China National Biotec Group Company Limited (CNBG), Sinopharm (BIBP’s COVID-19 Vaccine) for emergency use. According t...
View More +
Seychelles Becomes the Fourth Country that Approves BIBP’s COVID-19 Vaccine for Emergency Use
On February 25, 2021, the Ministry of Health (MOH) of Seychelles officially approved the Inactivated COVID-19 Vaccine (Vero Cell) developed by Beijing Institute of Biological Products Co., Ltd. (BIBP), China National Biotec Group Company Limited (CNBG), Sinopharm (BIBP’s COVID-19 Vaccine) for registration and marketing in Seychelles, making Seychelles the fou...
View More +
Hungary — The First EU Member that Approves BIBP’s COVID-19 Vaccine
Inactivated COVID-19 Vaccine (Vero Cell) of Beijing Institute of Biological Products Müller Cecília, Chief Medical Officer of Hungary, announced at a press conference on January 29 that, Hungary’s drug regulator gave use approval to the Inactivated COVID-19 Vaccine (Vero Cell) developed by Beijing Institute of Biological Products Co., L...
View More +
BIBP’s COVID-19 Vaccine Approved for Emergency Use in Iraq, Pakistan and Morocco!
Approved for Emergency Use in Iraq The Iraqi National Regulatory Authority has approved the Inactivated COVID-19 Vaccine (Vero Cell) developed by Beijing Institute of Biological Products Co., Ltd. (BIBP), China National Biotec Group Company Limited (CNBG), Sinopharm (“BIBP’s COVID-19 Vaccine”) for emergency use, as reported by Iraqi media on Ja...
View More +Contact us
